Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014
DateTitle 
09/11/18Invuity Announces Definitive Agreement to Be Acquired by Stryker Corporation for $7.40 Per Share in Cash
SAN FRANCISCO, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY), a leading medical technology company focused on advanced surgical devices to enable better visualization, today announced it has entered into a definitive agreement with Stryker Corporation (NYSE:SYK), pursuant to which Stryker will acquire all of the outstanding shares of Invuity for $7.40 per share in cash, implying a total equity value of approximately $190 million. "The combination of Stryker's established lea... 
Printer Friendly Version
08/14/18Invuity Announces Commercial Launch of PhotonGuide® Adapt for Vaginal Hysterectomy and Pelvic Organ Prolapse Procedures
SAN FRANCISCO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced the full commercial launch of PhotonGuide® Adapt, a novel system that consists of a flexible illuminator and a family of compatible retractors for surgical procedures performed vaginally including pelvic organ prolapse repairs and vaginal hysterectomies. PhotonGuide Adapt represents a new platform for Invuity. The flexible natu... 
Printer Friendly Version
08/02/18Invuity Announces 2018 Second Quarter, Six-Month Financial Results
SAN FRANCISCO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced financial results for the second quarter and six months ended June 30, 2018. Q2 2018 Highlights Second quarter 2018 revenue grew 7.5% to $10.5 million compared to revenue of $9.8 million in the second quarter of 2017. Disposable revenue in the second quarter of 2018 grew 11.5% to $9.2 million compared to $8.3 million in... 
Printer Friendly Version
07/20/18Invuity Announces 2018 Second Quarter Financial Results and Conference Call Date
SAN FRANCISCO, July 20, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that it will release its 2018 second quarter financial results after the market closes on Thursday, August 2, 2018. In conjunction with the release, the Company will host a conference call with the investment community at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on Thursday, August 2, 2018, to discuss the financial results ... 
Printer Friendly Version
05/29/18Invuity to Present at William Blair Annual Growth Stock Conference
SAN FRANCISCO, May 29, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that company management is scheduled to present at the 38th Annual Growth Stock Conference on Tuesday, June 12, 2018 at 9:30 a.m. Central Time in Chicago. A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.invuity.com under Investors ... 
Printer Friendly Version
05/14/18Invuity Announces Results of New PhotonBlade® Studies at 2018 Heart Rhythm Society Conference
Researchers identify critical factors to minimize damage when using electrocautery near insulated pacing leads and demonstrate a reduced risk of damaging lead insulation with the use of PhotonBlade SAN FRANCISCO, May 14, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced the results of two studies that were published at the Scientific Sessions of the Heart Rhythm Society in Boston last week.  The studie... 
Printer Friendly Version
05/03/18Invuity Announces First Quarter Financial Results
SAN FRANCISCO, May 03, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announces financial results for the three months ended March 31, 2018. Q1 2018 Highlights First quarter 2018 revenue grew 5.3% to $9.5 million compared to revenue of $9.0 million in the first quarter of 2017. Disposable revenue in the first quarter of 2018 grew 21.7% to $8.6 million compared to $7.0 million in the first quarter of 2... 
Printer Friendly Version
04/19/18Invuity Announces 2018 First Quarter Financial Results and Conference Call Date
SAN FRANCISCO, April 19, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that it will release its 2018 first quarter financial results after the market closes on Thursday, May 3, 2018. In conjunction with the release, the Company will host a conference call with the investment community at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Thursday, May 3, 2018, to discuss the financial results and ot... 
Printer Friendly Version
03/15/18Invuity Announces Pricing of Public Offering of Common Stock
SAN FRANCISCO, March 15, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY) (“Invuity” or the “Company”), a leading medical technology company focused on minimal access surgery, today announced the pricing of its public offering of 6,200,000 shares of its common stock at a price to the public of $3.50 per share. In addition, the Company has granted the underwriters a 30-day option to purchase up to 600,000 additional shares of its common stock. William Blair & Company, L.L.C. is acting... 
Printer Friendly Version
03/14/18Invuity Announces Proposed Public Offering of Common Stock
SAN FRANCISCO, March 14, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY) ("Invuity" or the "Company"), a leading medical technology company focused on minimal access surgery, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering. Invuity expects to grant the underwriters a 30-day option to purchase additional shares of its common stock. Invuity intends to use the net proceeds from the offer... 
Printer Friendly Version
02/28/18Invuity Announces Changes to Executive Leadership Team
Scott D. Flora appointed Interim President and Chief Executive Officer Philip Sawyer steps down as President and Chief Executive Officer SAN FRANCISCO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that Scott D. Flora, a member of the Company’s Board of Directors since 2017, has been appointed to serve as Interim President and Chief Executive Officer. This appointment follows Phil... 
Printer Friendly Version
02/13/18Invuity Announces Fourth Quarter and Full Year 2017 Financial Results
SAN FRANCISCO, Feb. 13, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announces financial results for the three months and year ended December 31, 2017. Q4 and full year 2017 Highlights Fourth quarter 2017 revenue grew 20% to $11.2 million compared to revenue of $9.4 million in the fourth quarter of 2016. Full year 2017 revenue grew 22% to $39.6 million compared to revenue of $32.5 million in 201... 
Printer Friendly Version
02/01/18Invuity to Present at Leerink Global Healthcare Conference
SAN FRANCISCO, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that company management is scheduled to present at Leerink Partners 7th Annual Global Healthcare Conference on Wednesday, February 14, 2018 at 10:00 a.m. Eastern Time in New York. A live, listen-only webcast of the presentation may be accessed by visiting the Events & Presentations section of the Company's website at www.in... 
Printer Friendly Version
01/31/18Invuity Announces 2017 Fourth Quarter, Full Year Financial Results and Conference Call Date
SAN FRANCISCO, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that it will release its 2017 fourth quarter and full year financial results after the market closes on Tuesday, February 13, 2018. In conjunction with the release, the Company will host a conference call with the investment community at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Tuesday, February 13, 2018, to discuss the ... 
Printer Friendly Version